Europe — EMA

Olmesartan Eg (Olmesartan Medoxomil)

Olmesartan medoxomil, the active ingredient in Olmesartan Eg, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to treat high blood pressure in adult patients.

Olmesartan Medoxomil

Request sourcing

Pack/s

What is Olmesartan Medoxomil?

Olmesartan medoxomil, the active ingredient in Olmesartan Eg, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to treat high blood pressure in adult patients. GNH USA supplies Olmesartan Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil used for?

Olmesartan Eg is an angiotensin II receptor blocker that helps manage conditions related to the renin‑angiotensin system.

- Hypertension: Lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure: Assists in controlling blood pressure and decreasing cardiac workload. - Diabetic nephropathy: Helps slow progression of kidney damage by controlling systemic pressure.

What are the side effects of Olmesartan Medoxomil?

Olmesartan Eg may cause adverse reactions in some patients.

Common Side Effects: - Dizziness . - Headache . - Fatigue . - Nasal congestion. - Diarrhea.

Serious or Rare Side Effects: - Angio‑Angi . - Hyper‑ . - Kidney . - Liver . - .

What precautions apply to Olmesartan Medoxomil?

When …

- t t " " ".

- ... t " " ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →